Dr. Douglas J. Darlin, MD

Dr. Darlin practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Darlin's NPI, 1851301287, was assigned on August 8, 2006. Dr. Darlin graduated from Loyola University Chicago Stritch School of Medicine in 1988. Dr. Darlin holds California license G67493.

Dr. Darlin's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Darlin's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Darlin is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Darlin to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Darlin practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Darlin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Darlin is board certified in urology by the American Board of Urology. Dr. Darlin is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and transurethral procedures among the conditions Dr. Darlin treats.

CMS data shows 661 Medicare services from Dr. Darlin across 12 procedure codes in 2024, for 248 Medicare patients. Medicare paid $60,752 for them. Every service was in an office.

CMS counts 248 Medicare patients who saw Dr. Darlin in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Darlin's median patient age at 71, with 24% women.

In 2024, Dr. Darlin wrote 897 Medicare Part D claims for 296 patients. 94% of them were for generic drugs. CMS names the drug for 804 of them, across 17 drugs with 11 or more claims each, at $38,923 in total drug cost. In 2023, CMS named 645 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Darlin for performance year 2024, reported as part of a group. Dr. Darlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Darlin as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Darlin. Dr. Darlin's most frequent co-author is Philippe E. Zimmern, MD.

CMS Open Payments shows 10 general payments to Dr. Darlin from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Coloplast Corp paid the most, $147.

Dr. Darlin graduated from Loyola University Chicago Stritch School of Medicine in 1988.

Dr. Darlin is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.